Biotech Product Offerings - C&EN Global Enterprise

STOCK MARKET Biotech firms drop initial public offerings amid

Nov 10, 2008 - The downturn in financial markets has stemmed the flow of capital for ... in 2006 and 2007, San Francisco merchant bank Burrill & Co. reports.

Chemical makers ready stock offerings - C&EN Global Enterprise

Chemical stock offerings are off to a strong start in 2017. The German specialty chemical firm AlzChem plans an initial public offering (IPO) of stock in the first half. Huntsman Corp., meanwhile, is pushing ahead with the IPO of its titanium dioxide

Chemical makers ready stock offerings - C&EN Global Enterprise

AlzChem and Venator prepare to offer shares in first half of 2017. Article Options. PDF (497 KB) · Full Text HTML · Abstract · Figures · Michael McCoy C&EN , 2017, 95 (4), pp 10â10January 23, 2017 ...

Biotech Earnings Mixed in Fourth Quarter - C&EN Global Enterprise

Nov 7, 2010 - On an overall basis, the fourth quarter of 1985 was a heady one for the biotechnology industry. The initial acquisition agreements for Hybritech (by Eli Lilly) and for Genetic Systems (by Bristol-Myers) put high values on the individual

Biotech firm Rubius raises $120 million - C&EN Global Enterprise

Rubius Therapeutics, a Cambridge, Mass.-based developer of red-blood-cell-based therapies, has raised $120 million in a financing round that included its founding investor, Flagship Pioneering, as well as other investors. Rubius engineers red blood c

BIOTECH FACES ITS PAST AND FUTURE - C&EN Global Enterprise

Talk show journalist Charlie Rose hosted an opening session panel consisting of founders of pioneer biotech companies who assessed the progress made by ...

Biotech firm readies microalgae products - C&EN Global Enterprise

Cyanotech, a biotechnology company based in Woodinville, Wash., "won't be profitable until 1988," says Arthur Karuna-Karan, president of the fledgling ...

USDA beefs up biotech regulatory process - C&EN Global Enterprise

However, on the same day, two studies not sponsored by USDA were released exploring the costs and benefits from the use of transgenic crops. Neither report's ...

Wacker turns to biotech | C&EN Global Enterprise - ACS Publications

... Sebastian Bray, a financial analyst for the German investment bank Berenberg, characterizes Wacker's financial predicament in an April 1 note to investors.

JSR will expand biotech manufacturing - C&EN Global Enterprise

In Durham, N.C., KBI will add two commercial-scale, single-use mammalian cell bioreactors to complement its clinical-scale reactors. In Boulder, Colo., it will add small-scale microbial fermentation capacity to complement larger-scale equipment. KBI

Biotech Product Offerings - C&EN Global Enterprise

Recommend Documents